Alzamend Neuro Stock Price Prediction
| ALZN Stock | USD 1.30 0.04 3.17% |
Oversold Vs Overbought
35
Oversold | Overbought |
EPS Estimate Current Year (14.50) | EPS Estimate Next Year (14.45) | Wall Street Target Price 35 | EPS Estimate Current Quarter (2.38) |
Using Alzamend Neuro hype-based prediction, you can estimate the value of Alzamend Neuro from the perspective of Alzamend Neuro response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Alzamend Neuro to buy its stock at a price that has no basis in reality. In that case, they are not buying Alzamend because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Alzamend Neuro after-hype prediction price | USD 1.32 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Alzamend |
Alzamend Neuro After-Hype Price Prediction Density Analysis
As far as predicting the price of Alzamend Neuro at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Alzamend Neuro or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Alzamend Neuro, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Alzamend Neuro Estimiated After-Hype Price Volatility
In the context of predicting Alzamend Neuro's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Alzamend Neuro's historical news coverage. Alzamend Neuro's after-hype downside and upside margins for the prediction period are 0.07 and 4.99, respectively. We have considered Alzamend Neuro's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Alzamend Neuro is very risky at this time. Analysis and calculation of next after-hype price of Alzamend Neuro is based on 3 months time horizon.
Alzamend Neuro Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Alzamend Neuro is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Alzamend Neuro backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Alzamend Neuro, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.90 | 3.67 | 0.02 | 0.08 | 6 Events / Month | 3 Events / Month | In about 6 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
1.30 | 1.32 | 1.54 |
|
Alzamend Neuro Hype Timeline
Alzamend Neuro is presently traded for 1.30. The entity has historical hype elasticity of 0.02, and average elasticity to hype of competition of 0.08. Alzamend is forecasted to increase in value after the next headline, with the price projected to jump to 1.32 or above. The average volatility of media hype impact on the company the price is over 100%. The price boost on the next news is projected to be 1.54%, whereas the daily expected return is presently at -0.9%. The volatility of related hype on Alzamend Neuro is about 3904.26%, with the expected price after the next announcement by competition of 1.38. Net Loss for the year was (9.95 M) with profit before overhead, payroll, taxes, and interest of 0. Given the investment horizon of 90 days the next forecasted press release will be in about 6 days. Check out Alzamend Neuro Basic Forecasting Models to cross-verify your projections.Alzamend Neuro Related Hype Analysis
Having access to credible news sources related to Alzamend Neuro's direct competition is more important than ever and may enhance your ability to predict Alzamend Neuro's future price movements. Getting to know how Alzamend Neuro's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Alzamend Neuro may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| TFFP | Tff Pharmaceuticals | (0.13) | 4 per month | 0.00 | (0.13) | 11.28 | (12.99) | 95.77 | |
| ELYM | Eliem Therapeutics | 0.25 | 4 per month | 0.00 | (0.19) | 6.21 | (9.35) | 34.87 | |
| INBX | Inhibrx | 1.00 | 6 per month | 2.72 | 0.01 | 5.54 | (6.11) | 16.80 | |
| ELVN | Enliven Therapeutics | (0.55) | 9 per month | 2.18 | 0.01 | 5.84 | (4.07) | 12.96 | |
| MOLN | Molecular Partners AG | (0.10) | 5 per month | 4.92 | (0.01) | 9.38 | (7.97) | 52.92 |
Alzamend Neuro Additional Predictive Modules
Most predictive techniques to examine Alzamend price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Alzamend using various technical indicators. When you analyze Alzamend charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Alzamend Neuro Predictive Indicators
The successful prediction of Alzamend Neuro stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Alzamend Neuro, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Alzamend Neuro based on analysis of Alzamend Neuro hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Alzamend Neuro's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Alzamend Neuro's related companies.
Story Coverage note for Alzamend Neuro
The number of cover stories for Alzamend Neuro depends on current market conditions and Alzamend Neuro's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Alzamend Neuro is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Alzamend Neuro's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Alzamend Neuro Short Properties
Alzamend Neuro's future price predictability will typically decrease when Alzamend Neuro's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Alzamend Neuro often depends not only on the future outlook of the potential Alzamend Neuro's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Alzamend Neuro's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 676.6 K | |
| Cash And Short Term Investments | 376 K |
Check out Alzamend Neuro Basic Forecasting Models to cross-verify your projections. To learn how to invest in Alzamend Stock, please use our How to Invest in Alzamend Neuro guide.You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alzamend Neuro. If investors know Alzamend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alzamend Neuro listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (142.87) | Return On Assets (2.14) | Return On Equity (44.08) |
The market value of Alzamend Neuro is measured differently than its book value, which is the value of Alzamend that is recorded on the company's balance sheet. Investors also form their own opinion of Alzamend Neuro's value that differs from its market value or its book value, called intrinsic value, which is Alzamend Neuro's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alzamend Neuro's market value can be influenced by many factors that don't directly affect Alzamend Neuro's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alzamend Neuro's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alzamend Neuro is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alzamend Neuro's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.